immunization

(redirected from Active immunization)
Also found in: Thesaurus, Medical, Legal, Financial, Encyclopedia, Wikipedia.

im·mu·nize

 (ĭm′yə-nīz′)
tr.v. im·mu·nized, im·mu·niz·ing, im·mu·niz·es
1. To render immune.
2. To produce immunity in, as by inoculation.
3. Law To grant immunity from prosecution or suit: immunize a witness.

im′mu·ni·za′tion (-nĭ-zā′shən) n.

im·mu·ni·za·tion

(ĭm′yə-nĭ-zā′shən)
1. The production of immunity to an infectious disease in an individual through inoculation or vaccination.
2. A specific inoculation or vaccination.

immunize verb
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.immunization - the act of making immune (especially by inoculation)immunization - the act of making immune (especially by inoculation)
protection - the activity of protecting someone or something; "the witnesses demanded police protection"
inoculation, vaccination - taking a vaccine as a precaution against contracting a disease
sensitising, sensitizing, sensitisation, sensitization - rendering an organism sensitive to a serum by a series of injections
Translations
imunizace
immuniseringvaccination
immunizálásvédõoltás
bólusetning, ónæmisaîgerî
imunizácia
bağışıklık kazandırma

immunization

[ˌɪmjʊnaɪˈzeɪʃən] N (Med) → inmunización f

immunization

[ˌɪmjʊnaɪˈzeɪʃən] immunisation (British) nimmunisation f

immunization

immunization

[ˌɪmjʊnaɪˈzeɪʃn] nimmunizzazione f

immune

(iˈmjuːn) adjective
(with to or from) protected against, or naturally resistant to, eg a disease. immune to measles; immune from danger.
imˈmunity noun
ˈimmunize, ˈimmunise (ˈimju-) verb
to make immune to a disease, especially by an injection of a weak form of the disease.
ˌimmuniˈzation, ˌimmuniˈsation noun

im·mu·ni·za·tion

n. inmunización, proceso para activar la producción de inmunidad en el organismo en contra de una determinada enfermedad.

immunization

n inmunización f; (vaccination) vacunación f
References in periodicals archive ?
They also will compare immunization with purified capsule polysaccharide as a preventive approach (active immunization) versus using capsule-specific antibodies as a therapy (passive immunization).
ACAM2000 is the only FDA-licensed vaccine for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.
TRUMENBA (Meningococcal Group B Vaccine) is a vaccine indicated for individuals 10 through 25 years of age for active immunization to prevent invasive disease caused by Neisseria meningitidis group B.
Pfizer Inc today announced that the European Medicines Agencys Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that TRUMENBA (Meningococcal Group B Vaccine) be granted marketing authorization in the European Union (EU) for active immunization of individuals 10 years and older to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB).3 The CHMPs opinion will now be sent to the European Commission (EC) for final decision.
Prior to this, the vaccine was only approved for active immunization against influenza A subtype viruses and type B viruses, in persons 3 years of age and older.
Food and Drug Administration (FDA) for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.
Food and Drug Administration (FDA) approval for an expanded age indication to include adults 18 through 49 years of age, in addition to the already approved indication for adults 50 years and older, for active immunization for the prevention of pneumonia and invasive disease caused by 13 Streptococcus pneumoniae (S.
ACAM2000 vaccine is the only vaccine licensed by the FDA for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.
VAXELIS is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b.
Moreover, most cases of severe RSV lower respiratory tract infection occur in otherwise healthy infants aged less than 5 months, when active immunization presents daunting challenges.
In agreement with our result, Naqvia et al [18] suggested that active immunization of non-prolific Malpura ewes against inhibinbased peptides could increase the ovulatory rate through increasing FSH concentrations.
This book traces the history of the anti-diphtheria campaign in Ireland and why Irish health authorities promoted active immunization and began a national program of mass childhood immunization, as well as describing the historical significance of diphtheria.